DD284599A5 - Verfahren zum herstellen einer pharmazeutischen tablette oder eines solchen bolus - Google Patents

Verfahren zum herstellen einer pharmazeutischen tablette oder eines solchen bolus Download PDF

Info

Publication number
DD284599A5
DD284599A5 DD88316593A DD31659388A DD284599A5 DD 284599 A5 DD284599 A5 DD 284599A5 DD 88316593 A DD88316593 A DD 88316593A DD 31659388 A DD31659388 A DD 31659388A DD 284599 A5 DD284599 A5 DD 284599A5
Authority
DD
German Democratic Republic
Prior art keywords
bolus
coating
tablet
strips
release
Prior art date
Application number
DD88316593A
Other languages
German (de)
English (en)
Inventor
Gautam R Ranade
Original Assignee
������@���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@���Kk�� filed Critical ������@���Kk��
Publication of DD284599A5 publication Critical patent/DD284599A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0068—Rumen, e.g. rumen bolus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/015—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/04—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating
    • A61L9/05—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating specially adapted to be released by contact with a liquid, e.g. for toilets

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Extrusion Moulding Of Plastics Or The Like (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Paper (AREA)
  • Communication Control (AREA)
  • Saccharide Compounds (AREA)
  • External Artificial Organs (AREA)
  • Cephalosporin Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Molding Of Porous Articles (AREA)
DD88316593A 1987-06-11 1988-06-09 Verfahren zum herstellen einer pharmazeutischen tablette oder eines solchen bolus DD284599A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/061,925 US4792448A (en) 1987-06-11 1987-06-11 Generic zero order controlled drug delivery system

Publications (1)

Publication Number Publication Date
DD284599A5 true DD284599A5 (de) 1990-11-21

Family

ID=22039041

Family Applications (1)

Application Number Title Priority Date Filing Date
DD88316593A DD284599A5 (de) 1987-06-11 1988-06-09 Verfahren zum herstellen einer pharmazeutischen tablette oder eines solchen bolus

Country Status (26)

Country Link
US (1) US4792448A (da)
EP (1) EP0294993B1 (da)
JP (1) JPH0688900B2 (da)
KR (1) KR900004092B1 (da)
CN (1) CN1018151B (da)
AT (1) ATE64850T1 (da)
AU (1) AU598938B2 (da)
CA (1) CA1326821C (da)
CS (1) CS274431B2 (da)
DD (1) DD284599A5 (da)
DE (1) DE3863493D1 (da)
DK (1) DK175285B1 (da)
EG (1) EG18919A (da)
ES (1) ES2022988B3 (da)
FI (1) FI94025C (da)
GR (1) GR3002260T3 (da)
IE (1) IE61123B1 (da)
IL (1) IL86631A (da)
MY (1) MY101285A (da)
NO (1) NO176162C (da)
NZ (1) NZ224981A (da)
PH (1) PH25174A (da)
PT (1) PT87701B (da)
RU (1) RU2072835C1 (da)
YU (1) YU46569B (da)
ZA (1) ZA884163B (da)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8815968D0 (en) * 1988-07-05 1988-08-10 Pfizer Ltd Veterinary devices
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
US4981870A (en) * 1989-03-07 1991-01-01 Pfizer Inc. Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants
US6361795B1 (en) * 1989-09-05 2002-03-26 Alza Corporation Method for lowering blood glucose
US5591454A (en) * 1989-09-05 1997-01-07 Alza Corporation Method for lowering blood glucose
US5629008A (en) * 1992-06-02 1997-05-13 C.R. Bard, Inc. Method and device for long-term delivery of drugs
US5256440A (en) * 1992-06-22 1993-10-26 Merck & Co., Inc. Process for producing a tablet core aperture
US5343550A (en) * 1993-02-25 1994-08-30 The United States Of America As Represented By The United States National Aeronautics And Space Administration Transversely polarized source cladding for an optical fiber
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US6726930B1 (en) * 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
CZ292360B6 (cs) * 1994-05-06 2003-09-17 Pfizer Inc. Dávkovací forma s řízeným uvolňováním obsahující azithromycin a způsob její výroby
US5534263A (en) * 1995-02-24 1996-07-09 Alza Corporation Active agent dosage form comprising a matrix and at least two insoluble bands
EP0811374A1 (en) * 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
TR199802616T2 (xx) 1996-06-17 1999-03-22 Janssen Pharmaceutica N.V. �ift-konveks, h�zl� par�alanan dozaj formlar�.
US6093420A (en) 1996-07-08 2000-07-25 Edward Mendell Co., Inc. Sustained release matrix for high-dose insoluble drugs
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
US20040208926A1 (en) * 1997-07-01 2004-10-21 Pfizer Inc Solubilized sertraline compositions
US20030133974A1 (en) * 1997-07-01 2003-07-17 Curatolo William John Encapsulated solution dosage forms of sertraline
AU739261B2 (en) 1997-07-01 2001-10-11 Pfizer Inc. Sertraline salts and sustained-release dosage forms of sertraline
WO1999007342A1 (en) * 1997-08-11 1999-02-18 Alza Corporation Prolonged release active agent dosage form adapted for gastric retention
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6485748B1 (en) 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
US6365183B1 (en) * 1998-05-07 2002-04-02 Alza Corporation Method of fabricating a banded prolonged release active agent dosage form
JP3893058B2 (ja) * 1999-09-30 2007-03-14 ペンウェスト ファーマシューティカルズ カンパニー 高度に可溶性の薬物のための徐放性マトリックス系
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US6837696B2 (en) 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
US7217381B2 (en) 2001-09-28 2007-05-15 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
BR0212950A (pt) 2001-09-28 2004-10-26 Mcneil Ppc Inc Formas de dosagens compósitas tendo uma porção inserida
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
ITMI20020515A1 (it) * 2002-03-12 2003-09-12 Jagotec Ag Sistema per il rilasco controllato di uno o piu' principi attivi
ES2298540T3 (es) 2002-04-04 2008-05-16 Pfizer Products Inc. Comprimido masticable agradable.
CN100435880C (zh) * 2003-02-28 2008-11-26 微创医疗器械(上海)有限公司 一种药物洗脱介入医疗器械及其制备方法
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US20040131672A1 (en) * 2003-01-07 2004-07-08 Nilobon Podhipleux Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
JP3811127B2 (ja) * 2003-01-30 2006-08-16 株式会社東芝 情報記録装置及び情報記録方法
WO2005051325A2 (en) * 2003-11-25 2005-06-09 Sb Pharmco Puerto Rico Inc. Carvedilol compositions methods of treatment and delivery
EP1691789B1 (en) * 2003-11-25 2017-12-20 SmithKline Beecham (Cork) Limited Carvedilol free base, salts, anhydrous forms or solvate thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
US9492541B2 (en) * 2004-09-14 2016-11-15 Sovereign Pharmaceuticals, Llc Phenylepherine containing dosage form
EP1696893A1 (en) * 2003-12-17 2006-09-06 Pfizer Products Incorporated Continuous combination therapy with selective prostaglandin ep4, receptor agonists and an estrogen for the treatment of conditions that present with low bone mass.
WO2006078320A2 (en) 2004-08-04 2006-07-27 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
US20060185678A1 (en) * 2005-02-03 2006-08-24 Bronnenkant Lance J Devices for delivering agents to a vaginal tract
US20060267774A1 (en) * 2005-03-24 2006-11-30 Feinberg Stewart C Transponder overmolded with ethylene copolymers
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7544373B2 (en) * 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7541347B2 (en) * 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US20080242642A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US9192615B2 (en) 2008-08-06 2015-11-24 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US7994220B2 (en) 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
EP1859788A1 (en) * 2006-05-24 2007-11-28 Abbott GmbH & Co. KG Production of enveloped pharmaceutical dosage forms
WO2008093578A1 (ja) * 2007-01-30 2008-08-07 Olympus Medical Systems Corp. 管腔通過確認装置、その溶解方法および製造方法
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
CN102821752A (zh) * 2009-09-22 2012-12-12 赢创德固赛公司 用于调整生物活性剂释放特征的植入装置
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
JP5879979B2 (ja) 2011-11-30 2016-03-08 ブラザー工業株式会社 分離片ユニットおよびシート搬送装置
GB2498999A (en) 2012-02-02 2013-08-07 Siemens Plc Mechanical superconducting switch
CN104490838B (zh) * 2014-11-20 2017-03-01 河北医科大学 一种骨架型缓控释片剂及其制备方法和应用
USD765828S1 (en) 2015-02-19 2016-09-06 Crossford International, Llc Chemical tablet
USD789514S1 (en) * 2016-06-01 2017-06-13 David Hill Injectable tablet
US10583089B2 (en) 2016-07-19 2020-03-10 Johnson & Johnson Consumer Inc. Tablets having discontinuous coated regions
CN109689030A (zh) * 2016-07-19 2019-04-26 强生消费者公司 具有不连续涂覆区域的片剂
JP2021524840A (ja) 2018-05-24 2021-09-16 セラニーズ・イーブイエイ・パフォーマンス・ポリマーズ・エルエルシー 高分子薬剤化合物の持続放出用の埋め込み型デバイス
WO2019226516A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
CN115209874A (zh) 2020-02-03 2022-10-18 强生消费者公司 包含西替利嗪的单层咀嚼片
LT4037666T (lt) 2020-12-08 2024-06-10 Ruminant Biotech Corp Limited Medžiagų pristatymo gyvūnams prietaisų ir būdų patobulinimai
USD979043S1 (en) * 2021-04-29 2023-02-21 Kurt A. Van Tine Tablet

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2539036A (en) * 1946-04-25 1951-01-23 Schwab Fritz Arrangement for applying chemicals and minerals for therapeutical purposes
US3113076A (en) * 1956-07-03 1963-12-03 Henry R Jacobs Medicinal tablets
GB972128A (en) * 1960-01-21 1964-10-07 Wellcome Found Pellets for supplying biologically active substances to ruminants and the manufacture of such pellets
NL175029C (nl) * 1970-12-23 1984-09-17 Boehringer Sohn Ingelheim Depotdragee, die bekleed is met een onoplosbare en onverteerbare schaal, die op een of meer plaatsen een uitsparing vertoont.
AT341100B (de) * 1972-12-27 1978-01-25 Alza Corp Verfahren zur herstellung eines korpers bzw. einer vorrichtung zur abgabe mit gesteuerter geschwindigkeit eines aktiven mittels
US3851648A (en) * 1973-10-11 1974-12-03 Mead Johnson & Co Zero-order release device
CH646330A5 (en) * 1980-05-21 1984-11-30 Ciba Geigy Ag Divisible slow-release pharmaceutical tablets
AU8363582A (en) * 1981-06-15 1982-12-23 Bally Manufacturing Corp. Surface projectile game
GB2110524B (en) * 1981-12-05 1985-06-12 Ronald Poppleton Hill Apparatus for dispensing a volatile material
US4690824A (en) * 1983-07-07 1987-09-01 Redi-Rowell, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range
AU591171B2 (en) * 1983-11-02 1989-11-30 Alza Corporation Dispenser for delivering thermo-responsive composition
IN162525B (da) * 1984-02-08 1988-06-04 Pfizer
US4609374A (en) * 1985-04-22 1986-09-02 Alza Corporation Osmotic device comprising means for governing initial time of agent release therefrom
US4673565A (en) * 1985-05-03 1987-06-16 E. I. Du Pont De Nemours And Company Pharmaceutical compositions containing hollow fine tubular drug delivery systems
GB8514666D0 (en) * 1985-06-11 1985-07-10 Coopers Animal Health Agent delivery systems
US4663147A (en) * 1985-09-03 1987-05-05 International Minerals & Chemical Corp. Disc-like sustained release formulation

Also Published As

Publication number Publication date
FI882780A (fi) 1988-12-12
FI94025B (fi) 1995-03-31
EP0294993A1 (en) 1988-12-14
IL86631A (en) 1991-09-16
ZA884163B (en) 1990-02-28
JPS649930A (en) 1989-01-13
EG18919A (en) 1994-06-30
RU2072835C1 (ru) 1997-02-10
PT87701A (pt) 1988-07-01
CN1030358A (zh) 1989-01-18
NO176162B (no) 1994-11-07
IL86631A0 (en) 1988-11-30
CA1326821C (en) 1994-02-08
US4792448A (en) 1988-12-20
NZ224981A (en) 1991-07-26
EP0294993B1 (en) 1991-07-03
YU46569B (sh) 1993-11-16
CN1018151B (zh) 1992-09-09
JPH0688900B2 (ja) 1994-11-09
YU112688A (en) 1990-04-30
NO882565D0 (no) 1988-06-10
GR3002260T3 (en) 1992-12-30
ATE64850T1 (de) 1991-07-15
DK175285B1 (da) 2004-08-09
KR900004092B1 (ko) 1990-06-15
IE61123B1 (en) 1994-10-05
FI882780A0 (fi) 1988-06-10
ES2022988B3 (es) 1991-12-16
DK318788D0 (da) 1988-06-10
FI94025C (fi) 1995-07-10
AU598938B2 (en) 1990-07-05
PH25174A (en) 1991-03-27
CS401188A2 (en) 1990-08-14
MY101285A (en) 1991-08-17
DK318788A (da) 1989-02-06
CS274431B2 (en) 1991-04-11
PT87701B (pt) 1992-09-30
AU1761488A (en) 1988-12-15
IE881763L (en) 1988-12-11
DE3863493D1 (de) 1991-08-08
NO176162C (no) 1995-02-15
KR890000081A (ko) 1989-03-11
NO882565L (no) 1988-12-12

Similar Documents

Publication Publication Date Title
DD284599A5 (de) Verfahren zum herstellen einer pharmazeutischen tablette oder eines solchen bolus
DE69207863T2 (de) Vorrichtung zur kontrollierten Wirkstoffreigabe
DD269124A5 (de) Vorrichtung zur kontrollierten freigabe einer aktiven substanz
DE69011878T2 (de) Von Hydrogel angetriebene Verabreichungsvorrichtung.
DE3876724T2 (de) Die zur freisetzung bioaktiver substanzen kontrollierende umhuellungszubereitung.
DE4341442C2 (de) Vorrichtung zur kontrollierten Freisetzung von Wirkstoffen sowie ihre Verwendung
DE69022876T2 (de) Arzneimittelformulierungen mit verzögerter Wirkstoffabgabe.
DE3587274T2 (de) Dosierungsform eine vielzahl mit einer diffusionshuelle ueberzogener einheiten enthaltend.
DE4431653C2 (de) Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung
DE3829942A1 (de) Dosierungsform zur abgabe von wirkstoffen
CH636276A5 (de) Durch osmose betaetigbare abgabevorrichtung.
CH625955A5 (da)
CH671696A5 (da)
DE3634864A1 (de) Abgabevorrichtung zur freisetzung einer auf temperatur ansprechenden masse
DE2448631A1 (de) Vorrichtung fuer eine nach nullter ordnung verlaufende freisetzung eines mittels
WO2013004813A1 (de) Quellfähige manteltablette
DE69007804T2 (de) Durch lyotrope Flüssigkristalle gesteuerte Abgabevorrichtung.
DE3400496A1 (de) Durch osmose wirksame vorrichtung zur abgabe eines wirkstoffs
DE3829941C2 (de) Abgabevorrichtung zur Verabreichung von Diltiazem
DE2343218C2 (de) Furosemid enthaltende Pellets
DE9200765U1 (de) Zusammensetzung für gesteuerte Wirkstoffabgabe
DE2918522C2 (de) Abgabevorrichtung zur kontrollierten und fortwährenden Zuführung einer Chemikalie während einer längeren Zeitspanne, Verwendung und Herstellverfahren dieser Vorrichtung
DE69004356T2 (de) Dosierungsformen mit intermittierender Freisetzung.
DE3626559A1 (de) Abgabevorrichtung zur verabreichung eines wirkstoffes an wiederkaeuer
HU213617B (en) Cylindric tablet or bolus for controlled release of one or more active substances into a fluid medium, bolus and tablet for ingestion active substances into constitucion of mammals, and process for producing them

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee